Novavax Reports Second Quarter 2020 Financial and Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
Novavax (NVAX) Tops Q2 EPS by 12c, Revenues Miss
August 10, 2020 4:33 PM EDTNovavax (NASDAQ: NVAX) reported Q2 EPS of ($0.30), $0.12 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $35.54 million versus the consensus estimate of $39.58 million.
Novavax unprecedented development activities for NVX-CoV2373 and progress continued through the second quarter, said Stanley C. Erck,... More
